Use of low-molecular-weight highly sulfated polysaccharide derivatives for modulating angiogenesis
US7833990B2 · kind B2 · utility
1Cited by
4References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 6, 2005 |
| Grant date | Nov 16, 2010 |
| Priority date | — |
| Expiry date | Feb 6, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of certain low-molecular weight highly sulphated polysaccharide derivatives obtained from a bacterial polysaccharide for preparing a pharmaceutical composition suitable for modulating angiogenesis, particularly for use in accelerating vascular endothelial repair with a low haemorrhage risk in the event of thrombotic injuries.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.